Australia Critical Care Diagnostics Market Size & Outlook
Australia critical care diagnostics market, 2018-2030 (US$M)
Related Markets
Australia critical care diagnostics market highlights
- The Australia critical care diagnostics market generated a revenue of USD 16.9 million in 2024 and is expected to reach USD 26.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 8.1% from 2025 to 2030.
- In terms of segment, immunoproteins was the largest revenue generating type in 2024.
- Microbial and Infectious Disease is the most lucrative type segment registering the fastest growth during the forecast period.
Critical care diagnostics market data book summary
| Market revenue in 2024 | USD 16.9 million |
| Market revenue in 2030 | USD 26.9 million |
| Growth rate | 8.1% (CAGR from 2025 to 2030) |
| Largest segment | Immunoproteins |
| Fastest growing segment | Microbial and Infectious Disease |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Routine and Special Chemistry, Flow Cytometry, Hematology, Immunoproteins, Microbial and Infectious Disease, Coagulation Testing |
| Key market players worldwide | Abbott Laboratories, Danaher Corp, Roche Holding AG ADR, BD, EKF Diagnostics Holdings PLC, BioMerieux SA, Siemens Healthineers AG ADR, Bayer AG, Chembio Diagnostic Systems Inc. |
Other key industry trends
- In terms of revenue, Australia accounted for 1.2% of the global critical care diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China critical care diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 95.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Critical Care Diagnostics Market Scope
Critical Care Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia critical care diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to critical care diagnostics market will help companies and investors design strategic landscapes.
Immunoproteins was the largest segment with a revenue share of 39.05% in 2024. Horizon Databook has segmented the Australia critical care diagnostics market based on routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious disease, coagulation testing covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia critical care diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia critical care diagnostics market databook
-
Our clientele includes a mix of critical care diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia critical care diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia critical care diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia critical care diagnostics market size, by type, 2018-2030 (US$M)
Australia Critical Care Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
